APA (7th ed.) Citation

Chan, J. L., Wu, S., Geis, A. L., Chan, G. V., Gomes, T. A., Beck, S. E., . . . Sears, C. L. (2019). Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A. Mucosal immunology, 12(1), 164-177. https://doi.org/10.1038/s41385-018-0085-5

Chicago Style (17th ed.) Citation

Chan, June L., et al. "Non-toxigenic Bacteroides Fragilis (NTBF) Administration Reduces Bacteria-driven Chronic Colitis and Tumor Development Independent of Polysaccharide A." Mucosal Immunology 12, no. 1 (2019): 164-177. https://doi.org/10.1038/s41385-018-0085-5.

MLA (9th ed.) Citation

Chan, June L., et al. "Non-toxigenic Bacteroides Fragilis (NTBF) Administration Reduces Bacteria-driven Chronic Colitis and Tumor Development Independent of Polysaccharide A." Mucosal Immunology, vol. 12, no. 1, 2019, pp. 164-177, https://doi.org/10.1038/s41385-018-0085-5.